Trial Profile
A Study to Evaluate the Antitumor Activity of Fulvestrant for the Treatment of Obese, Overweight and Normal Weight Postmenopausal Women With Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 19 May 2016 New trial record
- 10 May 2016 Results published in the Tumori